ENTERA BIO LTD. Income Taxes Paid
ENTERA BIO LTD. (ENTX) reported Income Taxes Paid of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2024-03-08
- ENTERA BIO LTD. income taxes paid, net for the quarter ending 2022-12-31 was $0.00.
- ENTERA BIO LTD. income taxes paid, net for the quarter ending 2021-12-31 was $0.00.
- ENTERA BIO LTD. income taxes paid, net for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ENTERA BIO LTD. income taxes paid, net for fiscal 2022 was $165.00K, a 8150.00% increase from fiscal 2021.
- ENTERA BIO LTD. income taxes paid, net for fiscal 2021 was $2.00K, a 97.75% decline from fiscal 2020.
- ENTERA BIO LTD. income taxes paid, net for fiscal 2020 was $89.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $165.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $165.00K 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-10 | ||
| 2020-12-31 | $89.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |